Adult
Aged
Aged, 80 and over
Antineoplastic Agents
Carcinoma, Papillary
Carcinoma, Renal Cell
Drug Therapy, Combination
Female
Humans
Immunologic Factors
Immunotherapy
Interferon-alpha
Interleukin-2
Kidney Neoplasms
Male
Middle Aged
Neoplasm Staging
Prognosis
Survival Rate
Treatment Outcome
